Skip to content

Evaluation of Scalpia hair strengthening tonic in reducing hair loss

Evaluation of safety and the effectiveness of Scalpia hair strengthening tonic in reducing diffuse and scattered hair loss and Improving hair volume and density

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT20190210042676N24
Enrollment
19
Registered
2022-05-18
Start date
2022-06-22
Completion date
Unknown
Last updated
2022-05-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hair loss. Nonscarring hair loss, unspecified

Interventions

Intervention group: Topical use of Scalpia hair strengthening tonic (Contains rosemary leaf extract, hops extract, licorice root extract, caffeine, glycerin, panthenol, nettle extract, sodium benzoate

Sponsors

Arachemi Pars company
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 55 Years

Inclusion criteria

Inclusion criteria: Male or female aged 18-55 years Diffuse and scattered hair loss (Count at least 300 hairs in a combing test over three days) General health Voluntary participation and signing written informed consent

Exclusion criteria

Exclusion criteria: Chronic active scalp disease other than hair loss Using any prescribed drug or Over The Counter(OTC) for hair loss within the past 3 months Any severe weight loss or strict diet therapy during the study Pregnancy or breastfeeding

Design outcomes

Primary

MeasureTime frame
Hair count changes. Timepoint: Before intervention, 6 and 12 weeks after the start of use. Method of measurement: Trichoscopy by Fotofinder.

Secondary

MeasureTime frame
Hair lost Changes, based on Global photographic review. Timepoint: Before intervention, 6 and 12 weeks after the start of use. Method of measurement: One independent dermatologist will perform clinical assessments in a blinded fashion by scoring every photograph according to the Global photographic review scale.;Changes in percentage of anagen to telogen. Timepoint: Before intervention, 6 and 12 weeks the start of use. Method of measurement: Trichoscopy by Fotofinder.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAniseh Samadi

Tehran University of Medical Sciences

aniseh_samadi@yahoo.com+98 21 8896 0880

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026